메뉴 건너뛰기




Volumn 38, Issue 2, 2006, Pages 496-498

Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

EID: 33645059975     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.12.047     Document Type: Conference Paper
Times cited : (29)

References (12)
  • 1
    • 7044269187 scopus 로고    scopus 로고
    • Antiviral therapy for hepatitis B after kidney transplantation
    • T.M. Chan Antiviral therapy for hepatitis B after kidney transplantation Transplant Proc 36 2004 2124
    • (2004) Transplant Proc , vol.36 , pp. 2124
    • Chan, T.M.1
  • 2
    • 1842577541 scopus 로고    scopus 로고
    • Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials
    • F. Fabrizi, G. Dulai, V. Dixit Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation meta-analysis of clinical trials Transplantation 77 2004 859
    • (2004) Transplantation , vol.77 , pp. 859
    • Fabrizi, F.1    Dulai, G.2    Dixit, V.3
  • 3
    • 18744387770 scopus 로고    scopus 로고
    • Lamivudine in the treatment of HBV-related liver disease after renal transplantation: An update
    • F. Fabrizi, P. Martin, S. Bunnapradist Lamivudine in the treatment of HBV-related liver disease after renal transplantation an update Int J Artif Organs 28 2005 211
    • (2005) Int J Artif Organs , vol.28 , pp. 211
    • Fabrizi, F.1    Martin, P.2    Bunnapradist, S.3
  • 4
    • 0035988261 scopus 로고    scopus 로고
    • Management of hepatitis B after renal transplantation: An update
    • F. Fabrizi, G. Lunghi, F.F. Poordad Management of hepatitis B after renal transplantation an update J Nephrol 15 2002 113
    • (2002) J Nephrol , vol.15 , pp. 113
    • Fabrizi, F.1    Lunghi, G.2    Poordad, F.F.3
  • 5
    • 0036829841 scopus 로고    scopus 로고
    • Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
    • T.M. Chan, G.X. Fang, C.S. Tang Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients Hepatology 36 2002 1246
    • (2002) Hepatology , vol.36 , pp. 1246
    • Chan, T.M.1    Fang, G.X.2    Tang, C.S.3
  • 6
    • 0035865376 scopus 로고    scopus 로고
    • Results on preemptive or prophylactic treatment of lamivudine in HBsAg(+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence
    • D.J. Han, T.H. Kim, S.K. Park Results on preemptive or prophylactic treatment of lamivudine in HBsAg(+) renal allograft recipients comparison with salvage treatment after hepatic dysfunction with HBV recurrence Transplantation 71 2001 387
    • (2001) Transplantation , vol.71 , pp. 387
    • Han, D.J.1    Kim, T.H.2    Park, S.K.3
  • 7
    • 0031456837 scopus 로고    scopus 로고
    • Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation
    • L. Rostaing, S. Henry, J.M. Cisterne Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation Transplantation 64 1997 1624
    • (1997) Transplantation , vol.64 , pp. 1624
    • Rostaing, L.1    Henry, S.2    Cisterne, J.M.3
  • 8
    • 0032572971 scopus 로고    scopus 로고
    • Treatment of chronic hepatitis B with lamivudine in renal transplant recipients
    • Y.O. Jung, Y.S. Lee, W.S. Yang Treatment of chronic hepatitis B with lamivudine in renal transplant recipients Transplantation 66 1998 733
    • (1998) Transplantation , vol.66 , pp. 733
    • Jung, Y.O.1    Lee, Y.S.2    Yang, W.S.3
  • 9
    • 0034669706 scopus 로고    scopus 로고
    • Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients
    • J. Kletzmayr, B. Watschinger, C. Muller Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients Transplantation 70 2000 1404
    • (2000) Transplantation , vol.70 , pp. 1404
    • Kletzmayr, J.1    Watschinger, B.2    Muller, C.3
  • 10
    • 0034720602 scopus 로고    scopus 로고
    • HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients
    • H. Fontaine, V. Thiers, Y. Chretien HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients Transplantation 69 2000 2090
    • (2000) Transplantation , vol.69 , pp. 2090
    • Fontaine, H.1    Thiers, V.2    Chretien, Y.3
  • 11
    • 12344270880 scopus 로고    scopus 로고
    • Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation
    • T.W. Lapinski, R. Flisiak, J. Jaroszewicz Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation World J Gastroenterol 11 2005 400
    • (2005) World J Gastroenterol , vol.11 , pp. 400
    • Lapinski, T.W.1    Flisiak, R.2    Jaroszewicz, J.3
  • 12
    • 0034536926 scopus 로고    scopus 로고
    • Chronic hepatitis B treatment with lamivudine in kidney transplant patients
    • C. Mouquet, B. Bernard, T. Poynard Chronic hepatitis B treatment with lamivudine in kidney transplant patients Transplant Proc 32 2000 2762
    • (2000) Transplant Proc , vol.32 , pp. 2762
    • Mouquet, C.1    Bernard, B.2    Poynard, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.